Table 1.

Demographics and characteristics of the subjects

CharacteristicAbacavirPlacebo
No. of subjects randomized126
 No. of men/no. of women9/36/0
 No. of whites/no. of blacks8/44/2
Age (yr)a 38 (24–48)30 (28–45)
Baseline CD4+ count (no. of cells/mm3)a 290 (61–713)375 (10–523)
No. of subjects with the following CDC classification:
 A103
 B 12
 C 11
Premature discontinuations (no. of subjects)
 Condition deteriorated 10
 Consent withdrawn 30
  • a Values are means (ranges).